'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once againFierce PharmaApr 16, 03:36 PM
Neurocrine, eying ‘blockbuster in the making,’ strikes its largest-ever M&A deal with $2.9B Soleno buyoutFierce PharmaApr 6, 02:30 PM
UK signs off on US pharma deal, ensuring tariff reprieve as Britain aims to reattract investmentsFierce PharmaApr 2, 07:34 PM